Aktiesnakken — Oktober 2010
-
laban det er GSK der komemr med Q3 i morgen. OLg i den forbindelse får vi arzerra salg
-
Nej. Det er fuldstændigt umuligt at regne ud hvad oms vil blive. Men jeg tror ikke marekdet vil tage godt imod mindre end 100 mio
-
så derfor er det det tal jeg vil holde øje med. Mere og det er nice. Mindre og det er skidt
-
narh det tror jeg som sådan ikke. Det er stadig en niche indikation vi taler om.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
så er vi begge i killings klassen